6600 POSTER A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of Capecitabine Plus Paclitaxel Followed by Capecitabine Maintenance (PX-X) With Capecitabine Plus Cisplatin (XP) as a First-line Chemotherapy for Recurrent or Metastatic Gastric Cancer (PAC-C Study)

✍ Scribed by Zhang, X.; Shen, L.; Lu, Z.; Hu, B.; Fan, Q.; Li, W.; Liu, W.; Liu, T.; Pan, Y.; Xu, N.

• Book ID: 122530263
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 60 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71911-6